Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Financial Results

Every financial results filing by a US-listed company that our alert engine sent, newest first.

6:33 PM ET 8-K
Financial Results Beneficient BENF

Beneficient Financial Results

Beneficient reported financial results for its fiscal 2027 second quarter ended September 30, 2026, highlighting a significant reduction in year-to-date operating expenses to $26.6 million from $95.1 million in the prior year. The company is advancing strategic initiatives to eliminate $130 million in purported debt associated with its former CEO and plans to launch AltLens, an AI-driven portfolio analytics platform.

Term
Q2 2027

“Our second quarter results for FY 2027 demonstrated that we are continuing to make progress on multiple fronts: advancing financing initiatives, executing collateral management transactions, monetizing assets, pursuing new originations and follow-on business, and reducing operating expenses. Beneficient remains focused on putting legacy matters behind it as it moves to the next phase of its development, and we believe AltLens will be an important part of that strategy.”

James Silk, Chief Executive Officer
6:33 PM ET 8-K
Financial Results XBP Global Holdings, Inc. XBP

XBP Global Holdings Financial Results

XBP Global reported Q3 2026 revenue of $182.8 million, a 12.6% year-over-year decline primarily due to planned client exits. Despite the revenue drop, the company achieved a record normalized EBITDA margin of 12.4% and reported its strongest bookings quarter since its 2025 merger, with $147.5 million in total contract value (TCV) bookings.

Term
Q3 2026

“In the third quarter, normalized EBITDA grew sequentially for the second consecutive quarter and normalized EBITDA margin reached 12.4%, the highest for the combined company, as our AI-first operating model continued to expand margins.”

Andrej Jonovic, Chief Executive Officer of XBP Global

“Revenue declined year-over-year largely as we anticipated, as client exits that began last year continued to run off. Commercially, this was our strongest bookings quarter since the combination in July 2025.”

Andrej Jonovic, Chief Executive Officer of XBP Global
6:33 PM ET 8-K
Financial Results Flyte Aviation, Inc. VJET

Flyte Aviation Financial Results

Flyte Aviation reported record Q3 2026 aviation revenue of $1.84 million, a 145% sequential increase driven by a 129% surge in flight hours. The company is expanding its fleet with three additional jets expected to enter service in Q4 2026 and recently secured regulatory clearance to begin operations in Canada.

Term
Q3 2026

“I am delighted with the rapid ramp up of Flyte’s revenue, aircraft utilization and more. Our financial and operating results combined with increasing customer demand further validates our business strategy of providing the convenience, comfort, time efficiency and reliability of short-hop private aviation at a highly competitive price.”

David Jenkins, Flyte Aviation CEO
6:33 PM ET 8-K
Financial Results Envela Corp ELA

Envela Financial Results

Envela Corp reported Q3 2026 financial results with revenue of $43.4 million and net income of $3.9 million. Despite a revenue decline from the prior year due to lower precious metals activity, the company expanded gross margins to 29.4% and grew operating income by 11.5%.

Term
Q3 2026

“Through nine months we have earned $0.65 per diluted share, nearly double the prior-year period and already more than all of 2025. Precious metals traded well below January’s record levels, customer selling normalized and Consumer revenue stepped down from last year’s elevated base. Even so, quarterly diluted earnings per share rose 15.4 percent to $0.15, operating income grew 11.5 percent to $4.7 million and gross margin expanded to 29.4 percent of revenue on a favorable sales mix. That is the model working as designed.”

John Loftus, CEO of Envela

“Consumer segment gross margin rose to 17.5 percent from 11.5 percent a year ago as mix shifted away from wholesale, and our Commercial segment grew revenue again on steady demand for re-commerced technology assets and components. We generated $33.5 million in operating cash flow year to date, retired the Consumer segment’s bank note, repurchased 67,435 shares and ended September with $35.6 million in net cash, up from $8.2 million at year-end.”

John Loftus, CEO of Envela
6:33 PM ET 8-K
Financial Results Lument Finance Trust, Inc. LFT

Lument Finance Trust Financial Results

Lument Finance Trust reported its third quarter 2026 financial results, posting a GAAP net loss of $13.5 million, or $2.57 per share. The company also reported a non-GAAP Distributable Loss of $0.7 million, or $0.13 per share, for the period ended September 30, 2026.

Term
Q3 2026
6:33 PM ET 10-Q
Financial Results Metech Group Inc. MEGR

Metech Group Q3 2026 Results: Net Income $303K, Up 41.8% YoY

Metech Group Inc. reported a significant increase in net income to $1,083,316 for the nine months ended September 30, 2026, compared to $501,013 in the prior year period, driven by a 18.4% growth in revenues. The company successfully alleviated its going concern doubt due to recent profitability and financial support from significant shareholders.

Key figure
Net income $303K · +41.8% YoY
6:33 PM ET 10-Q
Financial Results Stark Novus Financial Inc.

Stark Novus Financial Q3 2026 Results: Net Loss of $2.52M

Stark Novus Financial Inc. reported a net loss of $2.5 million for the quarter ended September 30, 2026, as it transitioned into insurance and wealth management services following its reorganization. The company's balance sheet shows a shift from a positive stockholders' equity of $2.6 million at the end of 2025 to a deficit of $2.3 million by September 2026.

Key figure
Net loss $2.52M
6:33 PM ET 10-Q
Financial Results Limitless X Holdings Inc.

Limitless X Holdings Q3 2026 Results: Net Loss of $2.34M, Loss Narrows

Limitless X Holdings Inc. reported a significant decline in net revenue to $143,399 for the nine months ended September 30, 2026, compared to $802,396 in the prior year. The company incurred a net loss of $34,096,665 during this period, driven largely by a $27.8 million loss on the conversion of Preferred C to Preferred D stock and high salary expenses.

Key figure
Net loss $2.34M
6:33 PM ET 10-Q
Financial Results Feel The World, Inc.

Feel The World Q3 2026 Results: Turns Profitable, Net Income $1.07M

Feel The World, Inc. reported a significant turnaround for the nine months ended September 30, 2026, with net income of $2.15 million compared to a net loss of $1.91 million in the prior year period. Revenue grew to $50.69 million, driven by improved gross margins and operational efficiencies, despite an accumulated deficit of $4.28 million.

Key figure
Net income $1.07M
6:33 PM ET 10-Q
Financial Results TruGolf Holdings, Inc. TRUG

TruGolf Holdings Q3 2026 Results: Net Loss of $2.08M, Loss Narrows

TruGolf Holdings reported a net loss of $3.98 million for the nine months ended September 30, 2026, a significant improvement from the $13.27 million loss in the prior year period. Revenue grew 16.8% to $16.13 million, while the company's stockholders' equity shifted to a deficit of $22,716 as of the end of the quarter.

Key figure
Net loss $2.08M
6:33 PM ET 10-Q
Financial Results Tevogen Inc. TVGN

Tevogen Q3 2026 Results: Net Loss of $7M, Loss Widens

Tevogen Inc. reported a net loss of $18.2 million for the nine months ended September 30, 2026, compared to $21.6 million in the prior year period. The company continues to operate with a significant stockholders' deficit of $11.3 million and relies on financing activities, including a $3.0 million loan and $3.0 million from pre-funded warrants, to fund its biotechnology and AI initiatives.

Key figure
Net loss $7M
6:33 PM ET 10-Q
Financial Results Lightstone Value Plus REIT III, Inc.

Lightstone Value Plus REIT III Q3 2026 Results: Net Loss of $4.34M

Lightstone Value Plus REIT III reported a net loss of $7.2 million for the nine months ended September 30, 2026, compared to a $3.3 million loss in the prior year, primarily driven by a $4.6 million impairment charge. Total assets decreased to $110.8 million from $117.2 million at year-end 2025, while total equity declined to $46.7 million due to the net loss and share redemptions.

Key figure
Net loss $4.34M
6:33 PM ET 10-Q
Financial Results Integrated Rail & Resources Inc.

Integrated Rail & Resources Q3 2026 Results: Net Income $2.02M, Down 66.3% YoY

Integrated Rail & Resources Inc. reported a net income of $685,749 for the nine months ended September 30, 2026, a significant recovery from a net loss of $5,562,621 in the prior year period, primarily driven by a $5.8 million gain from the change in fair value of warrant liabilities. Despite the net profit, the company maintains a stockholders' deficit of $16.2 million and notes substantial doubt about its ability to continue as a going concern as it works toward a 2028 facility in-service date.

Key figure
Net income $2.02M · -66.3% YoY
6:33 PM ET 10-Q
Financial Results Beneficient BENF

Beneficient Q2 2026 Results: Net Loss of $22.1M, Loss Widens

Beneficient reported a net loss of $39.4 million for the quarter ended September 30, 2026, compared to a loss of $17.9 million in the prior year period. Total assets decreased to $227.3 million from $238.8 million at fiscal year-end, while the company's accumulated deficit grew to $2.12 billion.

Key figure
Net loss $22.1M
6:32 PM ET 10-Q
Financial Results Vivos Therapeutics, Inc. VVOS

Vivos Therapeutics Q3 2026 Results: Net Loss of $1.95M, Loss Narrows

Vivos Therapeutics is transitioning from a legacy dentist-focused model to a medical-provider focused sales and distribution model, highlighted by the acquisition of The Sleep Center of Nevada and a transaction with SOD Sciences. The company faces significant challenges regarding its Nasdaq listing requirements and the integration of its new business model while managing substantial indebtedness.

Key figure
Net loss $1.95M
6:32 PM ET 10-Q
Financial Results Global Macro Trust

Global Macro Trust Q3 2026 Results: Turns Profitable, Net Income $3.03M

For the nine months ended September 30, 2026, Global Macro Trust reported a significant turnaround with a net income of $8,596,407 compared to a net loss of $3,561,629 in the prior year period. This performance was driven by $9,247,519 in total net realized and unrealized gains, primarily from futures and forward currency contracts, which offset a net investment loss of $636,505.

Key figure
Net income $3.03M
6:32 PM ET 10-Q
Financial Results Super League Enterprise, Inc. SLE

Super League Enterprise Q3 2026 Results: Net Loss of $2.88M, Loss Narrows

Super League Enterprise reported a net loss of $11.3 million for the nine months ended September 30, 2026, compared to $10.6 million in the prior year period, despite a 6% increase in revenue to $8.6 million. The company's balance sheet shows a significant decrease in cash and cash equivalents from $14.4 million at year-end 2025 to $4.4 million as of September 30, 2026.

Key figure
Net loss $2.88M
6:32 PM ET 10-Q
Financial Results Mangoceuticals, Inc. MGRX

Mangoceuticals Q3 2026 Results: Net Loss of $3.55M, Loss Narrows

Mangoceuticals, Inc. is a smaller reporting company and emerging growth company focused on scaling its operations and marketing its products. The filing highlights significant risks including a limited operating history, the need for additional funding, and reliance on third-party compounding pharmacies for products not approved by the FDA.

Key figure
Net loss $3.55M
6:32 PM ET 10-Q
Financial Results CDT Equity Inc. CDT

CDT Equity Q3 2026 Results: Net Loss of $4.58M, Loss Narrows

CDT Equity Inc. reported a net loss of $13.3 million for the nine months ended September 30, 2026, compared to $17.9 million in the prior year. The company significantly expanded its balance sheet through a $153.5 million equity method investment, resulting in total assets increasing from $5.7 million to $158.7 million.

Key figure
Net loss $4.58M
6:32 PM ET 10-Q
Financial Results Blusky AI Inc.

Blusky AI Q3 2026 Results: Net Loss of $569K, Loss Narrows

BluSky AI Inc. reported a net loss of $1,476,476 for the nine months ended September 30, 2026, compared to a net loss of $4,014,763 in the prior year period. The company remains in a stockholders' deficit position of $787,655, though it successfully raised $1,910,966 through common stock issuances during the period.

Key figure
Net loss $569K
6:32 PM ET 10-Q
Financial Results Longduoduo Co Ltd

Longduoduo Co Q1 2026 Results: Net Loss of $437K, Loss Widens

Longduoduo Co Ltd reported a significant revenue decline to $17,595 for the quarter ended September 30, 2026, compared to $658,764 in the prior year, primarily due to a sharp drop in commission revenue. The company realized a net loss of $474,167 for the period and underwent a corporate restructuring involving the deregistration of its Hong Kong subsidiary.

Key figure
Net loss $437K
6:32 PM ET 10-Q
Financial Results SDR Drone, Inc.

SDR Drone Q3 2026 Results: Net Loss of $182K, Loss Narrows

SDR Drone, Inc. reported a net loss of $598,438 for the nine months ended September 30, 2026, compared to a loss of $760,649 in the prior year period. The company remains in a development stage with zero revenue and a stockholders' deficit of $243,944, primarily driven by professional fees and non-cash expenses related to debt amortization and derivative liabilities.

Key figure
Net loss $182K
6:32 PM ET 10-Q
Financial Results ConnectM Technology Solutions, Inc.

ConnectM Technology Solutions Q3 2026 Results: Net Loss of $8.12M, Loss Widens

For the nine months ended September 30, 2026, ConnectM Technology Solutions reported revenues of $26.35 million, an increase from $24.31 million in the prior year. The company recorded a net loss attributable to stockholders of $2.32 million, significantly improved from a $12.18 million loss in 2025, primarily due to a $19.05 million gain on the disposal of discontinued operations.

Key figure
Net loss $8.12M
6:32 PM ET 10-Q
Financial Results Host Digital Inc. HOST

Host Digital Q3 2026 Results: Net Loss of $9.67M

Host Digital Inc. reported a net loss of $11.45 million for the eight months ended September 30, 2026, following a reverse acquisition and public offering in September 2026. The company generated $1.48 million in net sales during the period, while significantly expanding its balance sheet to $108.2 million in total assets, primarily through intangible assets and right-of-use assets.

Key figure
Net loss $9.67M
6:32 PM ET 10-Q
Financial Results Picard Medical, Inc. PMI

Picard Medical Q3 2026 Results: Net Loss of $2.22M, Loss Narrows

Picard Medical, Inc. is a newly public medical device company focused on total artificial heart therapy, reporting 2,661,574 shares outstanding as of November 12, 2026. The filing highlights significant risks including customer concentration, reliance on single-source suppliers, and an explanatory paragraph from its auditors regarding its ability to continue as a going concern.

Key figure
Net loss $2.22M
6:32 PM ET 10-Q
Financial Results Cyabra, Inc. CYAB

Cyabra Q3 2026 Results: Net Loss of $2.59M, Loss Narrows

Cyabra, Inc. reported revenues of $5.27 million for the nine months ended September 30, 2026, compared to $4.08 million in the prior year period. The company experienced a significant net loss of $16.8 million, driven by increased research and development and general administrative expenses following a business combination and PIPE financing.

Key figure
Net loss $2.59M
4:47 PM ET 10-Q
Financial Results NovelStem International Corp.

NovelStem International Q3 2026 Results: Net Loss of $84.3K, Loss Widens

NovelStem International Corp. reported a net loss of $225,105 for the nine months ended September 30, 2026, compared to a net income of $2,469,177 in the prior year period which was driven by one-time debt relief and investment disposal gains. The company continues to operate with a significant shareholders' deficit of $2.1 million and requires additional financing to sustain operations following the liquidation of its primary equity investment, NewStem.

Key figure
Net loss $84.3K
4:47 PM ET 10-Q
Financial Results ASP Isotopes Inc. ASPI

ASP Isotopes Q3 2026 Results: Net Loss of $30.9M, Loss Widens

The filing highlights significant volatility in natural gas and helium markets, noting that Henry Hub spot prices fluctuated between $2.54 and $30.72 per MMBtu in early 2026. Renergen faces substantial liquidity risks related to its debt covenants and capital expenditure requirements for Phase 2 expansion, while global helium supply remains constrained with spot prices exceeding $2,000/Mcf due to geopolitical disruptions.

Key figure
Net loss $30.9M
4:47 PM ET 10-Q
Financial Results Hydrofarm Holdings Group, Inc. HYFM

Hydrofarm Holdings Group Q3 2026 Results: Net Loss of $7.78M, Loss Narrows

Hydrofarm Holdings Group reported a significant decline in net sales to $14.5 million for the third quarter of 2026 compared to $29.4 million in the prior year, driven by industry oversupply and customer pricing pressures. The company recorded a net loss for the nine-month period of $33.0 million and reported a total stockholders' deficit of $93.9 million, raising concerns about its ability to continue as a going concern.

Key figure
Net loss $7.78M
4:46 PM ET 8-K
Financial Results Traws Pharma, Inc. TRAW

Traws Pharma Financial Results

Traws Pharma reported Q3 2026 financial results and provided clinical updates for its COVID-19 and influenza antiviral programs. The company highlighted positive Phase 2a results for ratutrelvir and plans to engage the FDA on a registration strategy for PAXLOVID-ineligible patients.

Term
Q3 2026

“We have made meaningful progress toward our goal of developing new treatment and prevention options for patients most vulnerable to serious respiratory viral diseases.”

Iain Dukes, MA, DPhil, Chief Executive Officer of Traws Pharma

“For tivoxavir marboxil, the tablet bridging study achieved its objectives, and toxicology retesting is complete. These results support further evaluation of TXM as a potential once-monthly oral influenza prevention option. We expect to resubmit the updated toxicology package in the fourth quarter.”

Iain Dukes, MA, DPhil, Chief Executive Officer of Traws Pharma

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.